What the FDA's Black Box Warning Removal Means for You

For more than 20 years, the label on menopausal hormone therapy carried one of the FDA’s most serious safety alerts, a black box warning citing cardiovascular disease, breast cancer, and dementia risk. Since 2003, that warning has quietly shaped how millions of women, and the doctors caring for them, thought about hormone therapy. Many women simply learned to live without it, or to live with symptoms they were told to accept.

In 2026, the FDA formally removed it.

Following a 2025 expert panel and HHS review, the FDA announced it would remove the black box warning from estrogen-containing hormone therapy products, with the labeling change taking effect in February 2026.It’s one of the most meaningful shifts in women’s health this year, and so many women still don’t know it happened.

On a recent episode of the Forum Health Integrative Medicine Podcast, Hormones by Design founder and Medical Director Melissa Miskell, DO, sat down with Andrew Petersen, DO, for a candid, generous conversation about what went wrong 25 years ago, and what the FDA still hasn’t fully corrected.

What Changed in 2026

Following that 2025 expert panel and HHS review, the FDA removed the black box warning covering cardiovascular disease, breast cancer, and probable dementia from hormone therapy labels. The change touches four categories of hormone therapy:

• Combined estrogen-progesterone therapy
• Systemic estrogen-alone therapy
• Systemic progestogen-alone therapy
• Topical vaginal estrogen

New labeling will also carry age-specific guidance, reflecting what the evidence has shown for years: many women see long-term benefits when hormone therapy begins within 10 years of menopause onset.

The Study Behind the Warning Was More Flawed Than Most People Realize

The original warning traces back to the Women’s Health Initiative (WHI) trial, launched about 25 years ago. As Dr. Miskell shares on the podcast, the trial was stopped early, and the physicians leading it were given only a few hours’ notice before the results were published in JAMA, with no real chance to weigh in or offer context.

The numbers behind the headlines were far less alarming than the fear that followed. For every 10,000 women in the trial, hormone therapy was associated with about 10 additional heart events, 11 additional strokes, and 10 additional breast cancer cases. At the same time, there were about 10 fewer cases of colon cancer and 10 fewer hip fractures. When researchers looked at these outcomes together, the overall difference was about 10 additional women out of every 10,000.

One detail rarely makes it into the headlines: the study excluded women who were already experiencing menopause symptoms, so participants wouldn’t drop out of the placebo group. That means the trial was never designed to notice whether hormone therapy helped women feel better. Its focus was disease risk in women who, on average, were 63 years old, many of them a decade or more past menopause, with a high rate of smoking and pre-existing cardiovascular risk factors. The WHI trial was never built to hear from the women in it.

What the FDA Still Hasn't Corrected

One important piece gets lost in much of the coverage of the warning’s removal: the WHI trial never included bioidentical hormones—the hormones designed to be chemically identical to what your body already makes, like estrogen, progesterone, and testosterone. The FDA’s correction acknowledges the age problem with the original study, but as Dr. Miskell put it on the podcast, “they’ve only half accounted for the mistake,” since the FDA still hasn’t addressed the fact that the therapy studied wasn’t bioidentical. The distinction matters because standard hormones simply don’t move through your body the way your own hormones do.

In practice, the warning coming off the label doesn’t mean every hormone prescription written from here forward will look the same or feel the same. A prescription for a standard hormone and a personalized, lab-guided bioidentical protocol is not interchangeable, even though both may now fall under the same relaxed labeling.

How Hormones by Design Approaches This Differently

With the warning removed, more physicians who've never prescribed hormone therapy before are likely to start writing prescriptions. That's part of why the care you'll find at Hormones by Design feels different from what most women encounter elsewhere.

• Your hormones are always tested before treatment begins. Rather than prescribing based on age or symptoms alone, we build your plan from your actual lab picture: estrogen, progesterone, testosterone, and additional markers depending on where you are in perimenopause or menopause.
• Testosterone is tested and prescribed for women as a matter of course, not an afterthought. It'sfrequently skipped in women's hormone panels elsewhere, even though it plays a real role in your energy, mood, and overall balance.
• Your care is built around the whole of you, not just a printout. Your symptoms and your labs are considered together, so your treatment reflects what you're actually living through, not only where a number falls on a chart.
• Your provider takes the time to understand what your body specifically needs, rather than applying the same protocol to every woman at the same life stage.

What This Means for You

If you were told years ago that hormone therapy was too risky to consider, or you’ve been managing menopause symptoms without it because of what you’d heard, this is worth a second look, with the understanding that not all hormone therapy is delivered the same way.

The science informing that original warning has evolved, along with the formulations and delivery methods available to women today. Now, the label has changed, too. But the label change alone doesn’t guarantee the personalized, lab-guided approach that makes the biggest difference in how you feel.

Ready to Talk About Your Options?

Schedule an appointment at one of our 5 Texas locations to discuss whether hormone therapy is right for you, based on where the science actually stands today, and what a personalized, bioidentical approach looks like for your body specifically.